ERRE, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 5.512
AS - Asia 3.263
SA - Sud America 2.000
EU - Europa 1.574
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 128
OC - Oceania 8
Totale 12.668
Nazione #
US - Stati Uniti d'America 5.333
BR - Brasile 1.778
SG - Singapore 1.367
CN - Cina 755
IT - Italia 321
UA - Ucraina 309
HK - Hong Kong 293
VN - Vietnam 290
DE - Germania 236
FR - Francia 156
FI - Finlandia 102
BD - Bangladesh 98
GB - Regno Unito 96
SE - Svezia 91
IN - India 78
AR - Argentina 70
CA - Canada 66
TR - Turchia 64
EC - Ecuador 57
MX - Messico 57
RU - Federazione Russa 55
IQ - Iraq 54
PL - Polonia 39
ZA - Sudafrica 39
JP - Giappone 33
KR - Corea 30
NL - Olanda 30
AT - Austria 26
UZ - Uzbekistan 26
CO - Colombia 25
ID - Indonesia 23
BE - Belgio 22
ES - Italia 22
PK - Pakistan 22
MA - Marocco 19
PY - Paraguay 19
VE - Venezuela 19
TN - Tunisia 16
EG - Egitto 15
JM - Giamaica 14
KE - Kenya 14
SA - Arabia Saudita 14
CL - Cile 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
NP - Nepal 11
PH - Filippine 10
CZ - Repubblica Ceca 9
KZ - Kazakistan 9
LT - Lituania 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
IL - Israele 8
JO - Giordania 8
PE - Perù 8
PS - Palestinian Territory 8
AU - Australia 7
IE - Irlanda 7
LB - Libano 7
IR - Iran 6
RO - Romania 6
AL - Albania 5
CH - Svizzera 5
CR - Costa Rica 5
GE - Georgia 5
HN - Honduras 5
OM - Oman 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
KG - Kirghizistan 4
MY - Malesia 4
PA - Panama 4
BY - Bielorussia 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
HR - Croazia 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
NI - Nicaragua 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BO - Bolivia 1
Totale 12.476
Città #
Dallas 1.613
Singapore 751
Chandler 594
San Jose 495
Ashburn 313
Hong Kong 283
Beijing 246
Council Bluffs 151
Jacksonville 151
Princeton 142
Columbus 139
São Paulo 139
Lauterbourg 101
Ho Chi Minh City 98
New York 86
Los Angeles 77
Sassari 75
Shanghai 68
Hanoi 67
Santa Clara 66
Munich 61
Belo Horizonte 59
Helsinki 58
Wilmington 56
Dearborn 54
Nanjing 49
Boardman 38
Rio de Janeiro 37
Tokyo 32
Warsaw 32
Frankfurt am Main 30
Seoul 30
Nanchang 28
Orem 28
Brasília 27
Chicago 27
Campinas 25
Ann Arbor 24
Atlanta 24
Brooklyn 24
London 24
Quito 24
Toronto 24
Chennai 23
San Francisco 23
Shenyang 23
The Dalles 23
Baghdad 22
Curitiba 22
Mexico City 22
Milan 22
Montreal 22
Stockholm 22
Tashkent 22
Johannesburg 21
Denver 20
Phoenix 20
Turku 20
Brussels 18
Florence 18
Istanbul 18
Mountain View 18
Falkenstein 17
Piracicaba 17
Porto Alegre 17
Santo André 17
Guayaquil 16
Amsterdam 15
Buffalo 15
Changsha 15
Düsseldorf 15
Fortaleza 15
Goiânia 15
Poplar 15
Ribeirão Preto 15
Ankara 14
Boston 14
Jiaxing 14
Mumbai 14
Osasco 14
Salvador 14
Buenos Aires 13
Dhaka 13
Guangzhou 13
Hangzhou 12
Hebei 12
Juiz de Fora 12
Nairobi 12
Vienna 12
Baku 11
Betim 11
Campo Grande 11
Caxias do Sul 11
Da Nang 11
Haiphong 11
Nuremberg 11
Seattle 11
São José dos Campos 11
Asunción 10
Grottaglie 10
Totale 7.375
Nome #
A case of eruptive neurofibroma in a woman with neurofibromatosis during treatment with methotrexate 242
Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. 202
Asymmetric dimethylarginine: a key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis? 187
Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens 186
Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis 182
Association Between Exposure to Heavy Metals and Systemic Sclerosis: the Levels of Al, Cd, Hg, and Pb in Blood and Urine of Patients 180
Association between lipoprotein levels and humoral reactivity to mycobacterium avium subsp. Paratuberculosis in multiple sclerosis, type 1 diabetes mellitus and rheumatoid arthritis 174
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 168
Clinical utility of anti-lipoarabinomannan antibodies testing for the diagnosis of tuberculous arthritis. 167
Significato clinico degli indici derivati dalle cellule figurate del sangue periferico come marcatori diagnostici dell’artrite reumatoide: studio caso – controllo. 165
A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis 158
Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross-Sectional Study 158
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases 157
PtpA and PknG proteins secreted by mycobacterium avium subsp. Paratuberculosis are recognized by sera from patients with rheumatoid arthritis: A case– Control study 156
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 154
Scleroderma sera induce reactive oxygen species (ROS)-dependent activation of collagen synthesis in human pulmonary vascular smooth muscle cells 153
Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case–control study 151
Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry 151
Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis 146
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 146
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology 145
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 144
Microbial players in autoimmunity: multicentric analysis of the association between Mycoplasma hominis serostatus and rheumatoid arthritis 139
Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis 139
Association between blood Pentraxin-3 concentrations and rheumatic diseases: A systematic review and meta-analysis 138
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 137
Reactive arthritis secondary to Hafnia alvei enterocolitis. 136
Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 135
Humoral response to microbial biomarkers in rheumatoid arthritis patients 135
Peripheral blood CD8+ T-cell profiles in patients with psoriatic arthritis: a cross-sectionale case-control study. 135
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 134
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 133
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 133
Is there a role for imatinib mesylate in the treatment of eosinophilic granulomatosis with polyangiitis? 133
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 131
Association between ischemia-modified albumin (IMA) and peripheral endothelial dysfunction in rheumatoid arthritis patients 129
Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension 129
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation? 129
Oxidative Stress-Dependent Activation Of Collagen Synthesis Is Induced In Human Pulmonary Vascular Smooth Muscle Cells By Scleroderma Sera and Predicts Pulmonary Vascular Disease 127
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 126
Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study 126
Visceral leishmaniasis among immunosuppressed patients with rheumatic diseases 122
NADPH-derived ROS generation drives fibrosis and endothelial-to-mesenchymal transition in systemic sclerosis: Potential cross talk with circulating miRNAs 122
Pachydermodactyly 121
Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study 119
Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis. 119
Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation 118
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study 118
Role of infections in the pathogenesis of rheumatoid arthritis: Focus on mycobacteria 118
Diagnostic accuracy of different blood cells-derived indexes in rheumatoid arthritis A cross-sectional study 118
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 112
Decoding the Microbiome's Influence on Rheumatoid Arthritis 112
Repurposing existing drugs for cardiovascular risk management: A focus on methotrexate 111
Mycobacterium tuberculosis lipoarabinomannan antibodies are associated to rheumatoid arthritis in Sardinian patients 111
The sclerodermic hand: a radiological and clinical study 111
Exposure of human pulmonary vascular smooth muscle cells to sera from patients with systemic sclerosis increases intracellular reactive oxygen species levels 111
Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age 110
Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis 108
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 105
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: Results from a multicentre cross-sectional study 104
Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus 102
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 102
Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study 101
Genetics of Behçet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients. 100
Sera from Rheumatoid Arthritis Patients Induce Oxidative Stress and Pro-Angiogenic and Profibrotic Phenotypes in Human Endothelial Cells 99
Circulating Fetuin-A concentrations in rheumatic diseases: a systematic review and meta-analysis 99
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis 98
Association of Rheumatoid Arthritis with Glucose-6-Phosphate Dehydrogenase Deficiency: Results from a Case-Control Study 96
Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications 96
Methotrexate and Cardiovascular Protection: Current Evidence and Future Directions 96
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 96
Plasma L-Ergothioneina measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection 95
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study 93
Plasma L-ergothioneine measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection 92
Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis? 91
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 91
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review 90
VEGF in psoriatic arthritis: Systematic review and meta-analysis 90
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 90
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 89
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 88
Disease activity and disability influence CV risk estimation and management of rheumatoid arthritis patients 87
Subclinical hypothyroidism and cardiovascular risk factors 87
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 87
Methotrexate and cardiovascular prevention: an appraisal of the current evidence 86
Current therapeutic strategies in connective tissue disease-associated interstitial lung disease: introduction to the special issue 86
Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature 84
Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP randomized clinical trial 82
Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages 82
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence 81
Diagnostic value of antifilaggrine antibodies (antibodies to cyclic citrullinated peptide and anti-keratin antibodies) for rheumatoid arthritis 75
Exploring endothelial dysfunction in major rheumatic diseases: current trends and future directions 75
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients 75
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 75
Iloprost attenuates oxidative stress-dependent activation of collagen synthesis induced by sera from scleroderma patients in human pulmonary microvascular endothelial cells 74
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 73
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients 72
Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis? 71
Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis 70
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine 69
Totale 11.851
Categoria #
all - tutte 53.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 0 0 1 1 3 7 7 27 34 42 56 146
2022/2023983 84 104 28 194 49 173 4 120 156 6 41 24
2023/2024373 47 25 9 9 63 29 5 51 1 6 47 81
2024/20253.701 32 25 177 126 129 149 252 750 1.181 569 180 131
2025/20265.558 257 1.226 761 792 629 322 750 133 206 280 130 72
2026/2027568 222 346 0 0 0 0 0 0 0 0 0 0
Totale 12.668